Portfolio (Quarterly)
Guide ↗
Defilade Capital Management, L.P.
· CIK 0002088557| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HSIC | SCHEIN HENRY INC | Healthcare | 624,037.0 | $46.0M | 6.46% | +304K | +94.8% | $73.70 | -1.4% |
| 2 | BDX | BECTON DICKINSON & CO | Healthcare | 279,210.0 | $43.9M | 6.16% | +198K | +243.8% | $157.23 | -6.5% |
| 3 | DXCM | DEXCOM INC | Healthcare | 538,762.0 | $33.8M | 4.75% | +294K | +120.0% | $62.80 | +3.6% |
| 4 | INSM | INSMED INC | Healthcare | 194,909.0 | $31.9M | 4.47% | +145K | +289.8% | $163.52 | -34.5% |
| 5 | ISRG | INTUITIVE SURGICAL INC | Healthcare | 67,681.0 | $31.2M | 4.38% | +22K | +48.2% | $460.99 | -4.6% |
| 6 | — | GLOBUS MED INC | — | 354,350.0 | $30.5M | 4.29% | +87K | +32.6% | $86.16 | — |
| 7 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 1,359,969.0 | $26.1M | 3.67% | +703K | +107.1% | $19.20 | -4.2% |
| 8 | OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | 1,504,536.0 | $22.4M | 3.15% | +270K | +21.9% | $14.91 | -13.5% |
| 9 | ELAN | ELANCO ANIMAL HEALTH INC | Healthcare | 931,121.0 | $22.3M | 3.13% | +530K | +132.0% | $23.93 | -16.7% |
| 10 | EVMN | EVOMMUNE INC | Healthcare | 678,589.0 | $15.6M | 2.19% | +463K | +215.0% | $22.99 | -4.8% |
| 11 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 1,487,645.0 | $12.6M | 1.77% | +806K | +118.2% | $8.47 | -1.1% |
| 12 | ELDN | ELEDON PHARMACEUTICALS INC | Healthcare | 3,564,127.0 | $11.0M | 1.54% | +274K | +8.3% | $3.08 | +16.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
96.2%
Financial Services
3.8%